Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS
Nature Cardiovascular Research
ISSN 2731-0590 · Springer Nature
Nature Cardiovascular Research: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 12.6 (journal website); hybrid open access; APC about USD 12,690; median 297 days to acceptance (55 articles, last 24 months); 179 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Nature Cardiovascular Research is published by Springer Nature and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Congenital heart defects research, Cardiac Fibrosis and Remodeling and Atherosclerosis and Cardiovascular Diseases, together about 31.2% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Nature Cardiovascular Research is dedicated to publishing original and important advances in cardiac, vascular and blood biology, covering fundamental, translational, clinical and public health research. The journal aims to expand our understanding of all aspects of the cardiovascular system and haematology during development and in health and disease, and accelerate the translation of this knowledge into clinics to advance diagnosis, treatment and prevention. Our broad scope encompasses not only basic and clinical research, but also the societal impacts of cardiovascular and blood disease, ensuring that published works reach the widest possible audience of scientists, clinicians and policymakers. For more information, see Aims & Scope.
From the journal's Aims & Scope
Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS
Editorial board by country: 1 in mainland China (about 8%); most named United States 5, United Kingdom 2, Germany 2, Mainland China 1, Italy 1 (12 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Congenital heart defects researchBiochemistry, Genetics and Molecular Biology11%
- Cardiac Fibrosis and RemodelingMedicine11%
- Atherosclerosis and Cardiovascular DiseasesImmunology and Microbiology9.3%
- Cardiac electrophysiology and arrhythmiasMedicine7.8%
- Cardiovascular Function and Risk FactorsMedicine6.8%
- Cardiomyopathy and Myosin StudiesMedicine6.2%
- Single-cell and spatial transcriptomicsBiochemistry, Genetics and Molecular Biology4.7%
- Tissue Engineering and Regenerative MedicineMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cardiac & Cardiovascular Systems | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cardiac & Cardiovascular Systems | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 12.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 13.5Publisher website ·
- CiteScore 2026-06
- 15.6LetPub ·
- SJR 2026-06
- 4.77LetPub ·
- SNIP 2026-06
- 2.38LetPub ·
- h-index
- 58OpenAlex ·
- i10-index
- 273OpenAlex ·
- 2-year mean citedness
- 7.78OpenAlex ·
- Self-citation rate
- 2.4%LetPub ·
- Share of gold OA articles
- 44.87%LetPub ·
Volume
- Articles per year
- 101LetPub ·
- Downloads per year (publisher) 2025
- 1,274,134Publisher website ·
Articles by year OpenAlex count · 881 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 123 | 39 | 65 |
| 2025 | 179 | 78 | 1,227 |
| 2024 | 179 | 82 | 2,449 |
| 2023 | 206 | 81 | 3,362 |
| 2022 | 192 | 98 | 4,798 |
| 2021 | 2 | 2 | 164 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
297 daysMedian, submission to acceptance · P25–P75 200 days – 433 days
- Acceptance to online
- median 38 days (55 articles)
- Submission to online
- median 341 days
- Sample
- 55 articles with submission and acceptance dates (332 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 12,690 / EUR 10,690 / GBP 9,190 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted8
- articleArticleLength not stated
- commentCommentLength not stated
- consensus statementConsensus StatementLength not stated
- news & viewsNews & ViewsLength not stated
- perspectivePerspectiveLength not stated
- research briefingResearch BriefingLength not stated
- research highlightResearch HighlightLength not stated
- review articleReview ArticleLength not stated
Policy excerpts from the journal's websitePeer review
- Peer review 3 – Editorial Process, Peer Review, Appeals & Transfers
Once you have submitted your manuscript, it goes through our editorial process. If your manuscript is sent out for peer review, you will receive an email asking you to read and sign our Editorial Policies. To appeal against a decision, or transfer your submission to another journal – Appeals and Transfers. ____________________________________________________________________________________________…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- ISSN
- 2731-0590
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Nature Cardiovascular Research
What CAS zone is Nature Cardiovascular Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Nature Cardiovascular Research is in Zone 1 of Medicine, and in Zone 1 of the minor category Cardiac & Cardiovascular Systems; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Nature Cardiovascular Research?
The journal's website gives an impact factor of 12.6 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 15.6, h-index 58.
How long does peer review take at Nature Cardiovascular Research?
Based on the dates recorded on 55 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 297 days (interquartile range 200–433 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Nature Cardiovascular Research based?
Of the 12 board members whose country the journal's board page names, 1 (about 8%) are in mainland China; the countries named most often are United States (5), United Kingdom (2) and Germany (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Nature Cardiovascular Research?
According to LetPub and DOAJ records, Nature Cardiovascular Research is indexed in ESCI and Scopus. The journal's website also lists Web of Science; that list has not been checked against each database.
Is Nature Cardiovascular Research open access, and what is the APC?
Nature Cardiovascular Research is a hybrid journal. For open-access publication: APC about USD 12,690.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .